DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Post-treatment control of HIV infection

Abstract

Antiretroviral therapy (ART) for HIV is not a cure. However, recent studies suggest that ART, initiated early during primary infection, may induce post-treatment control (PTC) of HIV infection with HIV RNA maintained at <50 copies per mL. We investigate the hypothesis that ART initiated early during primary infection permits PTC by limiting the size of the latent reservoir, which, if small enough at treatment termination, may allow the adaptive immune response to prevent viral rebound (VR) and control infection. We use a mathematical model of within host HIV dynamics to capture interactions among target cells, productively infected cells, latently infected cells, virus, and cytotoxic T lymphocytes (CTLs). Analysis of our model reveals a range in CTL response strengths where a patient may show either VR or PTC, depending on the size of the latent reservoir at treatment termination. Below this range, patients will always rebound, whereas above this range, patients are predicted to behave like elite controllers. As a result, using data on latent reservoir sizes in patients treated during primary infection, we also predict population-level VR times for non-controllers consistent with observations.

Authors:
 [1];  [2]
  1. The Pennsylvania State Univ., University Park, PA (United States); Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  2. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Publication Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1233166
Report Number(s):
LA-UR-14-27986
Journal ID: ISSN 0027-8424
Grant/Contract Number:  
R01-AI028433; UM1-AI100645; AC52-06NA25396
Resource Type:
Accepted Manuscript
Journal Name:
Proceedings of the National Academy of Sciences of the United States of America
Additional Journal Information:
Journal Volume: 112; Journal Issue: 17; Journal ID: ISSN 0027-8424
Publisher:
National Academy of Sciences, Washington, DC (United States)
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; HIV latency; post-treatment control; mathematical modeling; immune exhaustion

Citation Formats

Conway, Jessica M., and Perelson, Alan S. Post-treatment control of HIV infection. United States: N. p., 2015. Web. doi:10.1073/pnas.1419162112.
Conway, Jessica M., & Perelson, Alan S. Post-treatment control of HIV infection. United States. https://doi.org/10.1073/pnas.1419162112
Conway, Jessica M., and Perelson, Alan S. Mon . "Post-treatment control of HIV infection". United States. https://doi.org/10.1073/pnas.1419162112. https://www.osti.gov/servlets/purl/1233166.
@article{osti_1233166,
title = {Post-treatment control of HIV infection},
author = {Conway, Jessica M. and Perelson, Alan S.},
abstractNote = {Antiretroviral therapy (ART) for HIV is not a cure. However, recent studies suggest that ART, initiated early during primary infection, may induce post-treatment control (PTC) of HIV infection with HIV RNA maintained at <50 copies per mL. We investigate the hypothesis that ART initiated early during primary infection permits PTC by limiting the size of the latent reservoir, which, if small enough at treatment termination, may allow the adaptive immune response to prevent viral rebound (VR) and control infection. We use a mathematical model of within host HIV dynamics to capture interactions among target cells, productively infected cells, latently infected cells, virus, and cytotoxic T lymphocytes (CTLs). Analysis of our model reveals a range in CTL response strengths where a patient may show either VR or PTC, depending on the size of the latent reservoir at treatment termination. Below this range, patients will always rebound, whereas above this range, patients are predicted to behave like elite controllers. As a result, using data on latent reservoir sizes in patients treated during primary infection, we also predict population-level VR times for non-controllers consistent with observations.},
doi = {10.1073/pnas.1419162112},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
number = 17,
volume = 112,
place = {United States},
year = {Mon Apr 13 00:00:00 EDT 2015},
month = {Mon Apr 13 00:00:00 EDT 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 125 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy
journal, January 2011

  • Salgado, Maria; Rabi, S. Alireza; O'Connell, Karen A.
  • Retrovirology, Vol. 8, Issue 1
  • DOI: 10.1186/1742-4690-8-97

Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
journal, October 2013


HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication
journal, October 2005

  • Lambotte, O.; Boufassa, F.; Madec, Y.
  • Clinical Infectious Diseases, Vol. 41, Issue 7
  • DOI: 10.1086/433188

Elucidating the elite: mechanisms of control in HIV-1 infection
journal, December 2009

  • O’Connell, Karen A.; Bailey, Justin R.; Blankson, Joel N.
  • Trends in Pharmacological Sciences, Vol. 30, Issue 12
  • DOI: 10.1016/j.tips.2009.09.005

Effector mechanisms in HIV-1 infected elite controllers: Highly active immune responses?
journal, January 2010


HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
journal, April 2007

  • Saez-Cirion, A.; Lacabaratz, C.; Lambotte, O.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 16
  • DOI: 10.1073/pnas.0611244104

Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
journal, December 2009

  • Okulicz, Jason F.; Marconi, Vincent C.; Landrum, Michael L.
  • The Journal of Infectious Diseases, Vol. 200, Issue 11
  • DOI: 10.1086/646609

The Challenge of Finding a Cure for HIV Infection
journal, March 2009


HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
journal, June 2009

  • Chomont, Nicolas; El-Far, Mohamed; Ancuta, Petronela
  • Nature Medicine, Vol. 15, Issue 8
  • DOI: 10.1038/nm.1972

Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection
journal, July 1998

  • Chun, T. -W.; Engel, D.; Berrey, M. M.
  • Proceedings of the National Academy of Sciences, Vol. 95, Issue 15
  • DOI: 10.1073/pnas.95.15.8869

Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection
journal, March 2012


Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
journal, July 2014

  • Whitney, James B.; Hill, Alison L.; Sanisetty, Srisowmya
  • Nature, Vol. 512, Issue 7512
  • DOI: 10.1038/nature13594

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
journal, May 1997

  • Chun, Tae-Wook; Carruth, Lucy; Finzi, Diana
  • Nature, Vol. 387, Issue 6629
  • DOI: 10.1038/387183a0

Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
journal, February 2013


Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
journal, May 2003

  • Siliciano, Janet D.; Kajdas, Joleen; Finzi, Diana
  • Nature Medicine, Vol. 9, Issue 6
  • DOI: 10.1038/nm880

Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
journal, October 2013


A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients
journal, April 2011


Modeling HIV persistence, the latent reservoir, and viral blips
journal, September 2009


Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts
journal, January 2013

  • Hocqueloux, Laurent; Avettand-Fènoël, Véronique; Jacquot, Sophie
  • Journal of Antimicrobial Chemotherapy, Vol. 68, Issue 5
  • DOI: 10.1093/jac/dks533

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection
journal, January 2003


Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
journal, May 2008

  • Keele, B. F.; Giorgi, E. E.; Salazar-Gonzalez, J. F.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 21
  • DOI: 10.1073/pnas.0802203105

A Highly Intensified ART Regimen Induces Long-Term Viral Suppression and Restriction of the Viral Reservoir in a Simian AIDS Model
journal, June 2012


HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
journal, March 1996


Decay characteristics of HIV-1-infected compartments during combination therapy
journal, May 1997

  • Perelson, Alan S.; Essunger, Paulina; Cao, Yunzhen
  • Nature, Vol. 387, Issue 6629
  • DOI: 10.1038/387188a0

Estimation and Prediction With HIV-Treatment Interruption Data
journal, January 2007


Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
journal, January 2000


Revisiting Immune Exhaustion During HIV Infection
journal, December 2010


PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention
journal, May 2009


Vaccination Alters the Balance between Protective Immunity, Exhaustion, Escape, and Death in Chronic Infections
journal, March 2011

  • Johnson, P. L. F.; Kochin, B. F.; McAfee, M. S.
  • Journal of Virology, Vol. 85, Issue 11
  • DOI: 10.1128/JVI.00166-11

Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection
journal, May 2012

  • Archin, N. M.; Vaidya, N. K.; Kuruc, J. D.
  • Proceedings of the National Academy of Sciences, Vol. 109, Issue 24
  • DOI: 10.1073/pnas.1120248109

Modeling Plasma Virus Concentration during Primary HIV Infection
journal, April 2000

  • Stafford, Max A.; Corey, Lawrence; Cao, Yunzhen
  • Journal of Theoretical Biology, Vol. 203, Issue 3
  • DOI: 10.1006/jtbi.2000.1076

Treatment-Mediated Alterations in HIV Fitness Preserve CD4+ T Cell Counts but Have Minimal Effects on Viral Load
journal, November 2010


Quantifying T lymphocyte turnover
journal, June 2013


Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans
journal, September 2013


Stochastic Analysis of Pre- and Postexposure Prophylaxis against HIV Infection
journal, January 2013

  • Conway, Jessica M.; Konrad, Bernhard P.; Coombs, Daniel
  • SIAM Journal on Applied Mathematics, Vol. 73, Issue 2
  • DOI: 10.1137/120876800

Stochastic Theory of Early Viral Infection: Continuous versus Burst Production of Virions
journal, February 2011


A Stochastic Model for Early HIV-1 Population Dynamics
journal, December 1998

  • Tuckwell, Henry C.; Le Corfec, Emmanuelle
  • Journal of Theoretical Biology, Vol. 195, Issue 4
  • DOI: 10.1006/jtbi.1998.0806

Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection
journal, August 2004


Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
journal, August 2014

  • Hill, Alison L.; Rosenbloom, Daniel I. S.; Fu, Feng
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 37
  • DOI: 10.1073/pnas.1406663111

Pharmaceutical approaches to eradication of persistent HIV infection
journal, February 2009

  • Bowman, Mary-Catherine; Archin, Nancie M.; Margolis, David M.
  • Expert Reviews in Molecular Medicine, Vol. 11
  • DOI: 10.1017/S1462399409000970

Early Antiretroviral Therapy and Mortality among HIV-Infected Infants
journal, November 2008

  • Violari, Avy; Cotton, Mark F.; Gibb, Diana M.
  • New England Journal of Medicine, Vol. 359, Issue 21
  • DOI: 10.1056/NEJMoa0800971

Viral and Latent Reservoir Persistence in HIV-1–Infected Patients on Therapy
journal, January 2006


Immune impairment thresholds in HIV infection
journal, April 2009


The Dual Role of CD4 T Helper Cells in the Infection Dynamics of HIV and Their Importance for Vaccination
journal, February 2002

  • Korthals Altes, H.; Wodarz, D.; Jansen, V. A. A.
  • Journal of Theoretical Biology, Vol. 214, Issue 4
  • DOI: 10.1006/jtbi.2001.2483

The race between initial T–helper expansion and virus growth upon HIV infection influences polyclonality of the response and viral set–point
journal, July 2003

  • Altes, H. Korthals; Ribeiro, R. M.; de Boer, R. J.
  • Proceedings of the Royal Society of London. Series B: Biological Sciences, Vol. 270, Issue 1522
  • DOI: 10.1098/rspb.2003.2377

Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation
journal, March 2013

  • Henrich, T. J.; Hu, Z.; Li, J. Z.
  • Journal of Infectious Diseases, Vol. 207, Issue 11
  • DOI: 10.1093/infdis/jit086

Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals
journal, June 2013

  • Moir, Susan; Fauci, Anthony S.
  • Immunological Reviews, Vol. 254, Issue 1
  • DOI: 10.1111/imr.12067

Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
journal, August 2013

  • Kwong, Peter D.; Mascola, John R.; Nabel, Gary J.
  • Nature Reviews Immunology, Vol. 13, Issue 9
  • DOI: 10.1038/nri3516

Dendritic cell based vaccines for HIV infection: The way ahead
journal, November 2013

  • García, Felipe; Plana, Montserrat; Climent, Nuria
  • Human Vaccines & Immunotherapeutics, Vol. 9, Issue 11
  • DOI: 10.4161/hv.25876

Therapeutic and prophylactic DNA vaccines for HIV-1
journal, January 2013

  • Ramirez, Lorenzo Antonio; Arango, Tatiana; Boyer, Jean
  • Expert Opinion on Biological Therapy, Vol. 13, Issue 4
  • DOI: 10.1517/14712598.2013.758709

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
journal, July 2012

  • Archin, N. M.; Liberty, A. L.; Kashuba, A. D.
  • Nature, Vol. 487, Issue 7408
  • DOI: 10.1038/nature11286

Reactivation of latent HIV by histone deacetylase inhibitors
journal, June 2013


Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
journal, June 2009


Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation
journal, April 2011

  • Xing, S.; Bullen, C. K.; Shroff, N. S.
  • Journal of Virology, Vol. 85, Issue 12
  • DOI: 10.1128/JVI.02033-10

A Stochastic Model for Early HIV-1 Population Dynamics
journal, December 1998

  • Tuckwell, Henry C.; Le Corfec, Emmanuelle
  • Journal of Theoretical Biology, Vol. 195, Issue 4
  • DOI: 10.1006/jtbi.1998.0806

Effector mechanisms in HIV-1 infected elite controllers: Highly active immune responses?
journal, January 2010


Immune impairment thresholds in HIV infection
journal, April 2009


Modeling HIV persistence, the latent reservoir, and viral blips
journal, September 2009


Enumeration of latently infected CD4+ T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay
journal, January 2004

  • Fondere, Jean-Michel; Planas, Jean-François; Huguet, Marie-France
  • Journal of Clinical Virology, Vol. 29, Issue 1
  • DOI: 10.1016/s1386-6532(03)00083-0

Erratum: Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
journal, August 2012

  • Archin, N. M.; Liberty, A. L.; Kashuba, A. D.
  • Nature, Vol. 489, Issue 7416
  • DOI: 10.1038/nature11455

Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
journal, August 2013

  • Kwong, Peter D.; Mascola, John R.; Nabel, Gary J.
  • Nature Reviews Immunology, Vol. 13, Issue 9
  • DOI: 10.1038/nri3516

Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
journal, November 2013

  • Persaud, Deborah; Gay, Hannah; Ziemniak, Carrie
  • New England Journal of Medicine, Vol. 369, Issue 19
  • DOI: 10.1056/nejmoa1302976

Stochastic variability in HIV affects viral eradication
journal, September 2014

  • Rouzine, Igor M.; Razooky, Brandon S.; Weinberger, Leor S.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 37
  • DOI: 10.1073/pnas.1413362111

HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication
journal, October 2005

  • Lambotte, O.; Boufassa, F.; Madec, Y.
  • Clinical Infectious Diseases, Vol. 41, Issue 7
  • DOI: 10.1086/433188

Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV
journal, January 2009


Emerging strategies to deplete the HIV reservoir
journal, January 2014


The race between initial T–helper expansion and virus growth upon HIV infection influences polyclonality of the response and viral set–point
journal, July 2003

  • Altes, H. Korthals; Ribeiro, R. M.; de Boer, R. J.
  • Proceedings of the Royal Society of London. Series B: Biological Sciences, Vol. 270, Issue 1522
  • DOI: 10.1098/rspb.2003.2377

HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
journal, March 1996


Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection
journal, March 2012


Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
journal, February 2013


Works referencing / citing this record:

Within-host and synaptic transmissions: contributions to the spread of HIV infection: A. R. M. CARVALHO AND C. M. A. PINTO
journal, June 2016

  • Carvalho, Ana R. M.; Pinto, Carla M. A.
  • Mathematical Methods in the Applied Sciences, Vol. 40, Issue 4
  • DOI: 10.1002/mma.4047

Stochastic Dynamics of the Latently Infected Cell Reservoir During HIV Infection
journal, October 2018


Modeling HIV Dynamics Under Combination Therapy with Inducers and Antibodies
journal, June 2019


Functional cure of HIV: the scale of the challenge
journal, November 2018

  • Davenport, Miles P.; Khoury, David S.; Cromer, Deborah
  • Nature Reviews Immunology, Vol. 19, Issue 1
  • DOI: 10.1038/s41577-018-0085-4

Why and where an HIV cure is needed and how it might be achieved
journal, December 2019


Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection
journal, June 2018


Modeling the Effects of Morphine-Altered Virus Specific Antibody Responses on HIV/SIV Dynamics
journal, April 2019


Probabilistic control of HIV latency and transactivation by the Tat gene circuit
journal, November 2018

  • Cao, Youfang; Lei, Xue; Ribeiro, Ruy M.
  • Proceedings of the National Academy of Sciences, Vol. 115, Issue 49
  • DOI: 10.1073/pnas.1811195115

Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
journal, January 2016

  • Delagrèverie, Héloïse M.; Delaugerre, Constance; Lewin, Sharon R.
  • Open Forum Infectious Diseases, Vol. 3, Issue 4
  • DOI: 10.1093/ofid/ofw189

Herpes simplex virus-2 dynamics as a probe to measure the extremely rapid and spatially localized tissue-resident T-cell response
journal, August 2018

  • Schiffer, Joshua T.; Swan, David A.; Prlic, Martin
  • Immunological Reviews, Vol. 285, Issue 1
  • DOI: 10.1111/imr.12672

Mathematical modeling of within-host Zika virus dynamics
journal, August 2018

  • Best, Katharine; Perelson, Alan S.
  • Immunological Reviews, Vol. 285, Issue 1
  • DOI: 10.1111/imr.12687

Insight into treatment of HIV infection from viral dynamics models
journal, August 2018

  • Hill, Alison L.; Rosenbloom, Daniel I. S.; Nowak, Martin A.
  • Immunological Reviews, Vol. 285, Issue 1
  • DOI: 10.1111/imr.12698

Might dolutegravir be part of a functional cure for HIV?
journal, May 2016

  • Wainberg, Mark A.; Han, Ying-Shan; Mesplède, Thibault
  • Canadian Journal of Microbiology, Vol. 62, Issue 5
  • DOI: 10.1139/cjm-2015-0725

From Individual Health to Community Health: Towards Multiscale Modeling of Directly Transmitted Infectious Disease Systems
journal, March 2019


Dual targeting of the thioredoxin and glutathione systems in cancer and HIV
journal, May 2016

  • Benhar, Moran; Shytaj, Iart Luca; Stamler, Jonathan S.
  • Journal of Clinical Investigation, Vol. 126, Issue 5
  • DOI: 10.1172/jci85339

Life cycle synchronization is a viral drug resistance mechanism
journal, February 2018


Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents
journal, February 2018


Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
journal, July 2019


Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV
journal, April 2016


HIV control: Is getting there the same as staying there?
journal, November 2018


CD8+ lymphocyte control of SIV infection during antiretroviral therapy
journal, October 2018


Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
journal, June 2018


Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV
text, January 2016

  • Hill, Alison L.; Rosenbloom, Daniel; Goldstein, Edward
  • Columbia University
  • DOI: 10.7916/d8m61k94

A dynamical motif comprising the interactions between antigens and CD8 T cells may underlie the outcomes of viral infections
journal, August 2019

  • Baral, Subhasish; Antia, Rustom; Dixit, Narendra M.
  • Proceedings of the National Academy of Sciences, Vol. 116, Issue 35
  • DOI: 10.1073/pnas.1902178116

HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers
text, January 2018

  • R., Mitsuyasu,; M., Lichterfeld,; G. Q., Lee,
  • American Society for Clinical Investigation
  • DOI: 10.17615/z2cw-gb29

Life cycle synchronization is a viral drug resistance mechanism
text, January 2018

  • Neagu, Iulia A.; Olejarz, Jason; Freeman, Mark
  • Columbia University
  • DOI: 10.7916/d8vq4jks

Towards multiscale modeling of the CD8 + T cell response to viral infections
journal, February 2019

  • Baral, Subhasish; Raja, Rubesh; Sen, Pramita
  • WIREs Systems Biology and Medicine, Vol. 11, Issue 4
  • DOI: 10.1002/wsbm.1446

Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection
journal, June 2018


Modeling the Effects of Morphine-Altered Virus Specific Antibody Responses on HIV/SIV Dynamics
journal, April 2019


Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
journal, January 2016

  • Delagrèverie, Héloïse M.; Delaugerre, Constance; Lewin, Sharon R.
  • Open Forum Infectious Diseases, Vol. 3, Issue 4
  • DOI: 10.1093/ofid/ofw189

Windows of opportunity for Ebola virus infection treatment and vaccination
posted_content, April 2017

  • Nguyen, Van Kinh; Hernandez-Vargas, Esteban A.
  • bioRxiv
  • DOI: 10.1101/125336

Analysis of an HIV model with post-treatment control
journal, January 2020

  • Wang, Shaoli; Xu, Fei
  • Journal of Applied Analysis & Computation, Vol. 10, Issue 2
  • DOI: 10.11948/20190081

Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents
journal, February 2018


Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
journal, July 2019


Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV
journal, April 2016


Modeling Kick-Kill Strategies toward HIV Cure
journal, August 2017


Monotonic and nonmonotonic immune responses in viral infection systems
journal, January 2022

  • Wang, Shaoli; Li, Huixia; Xu, Fei
  • Discrete & Continuous Dynamical Systems - B, Vol. 27, Issue 1
  • DOI: 10.3934/dcdsb.2021035

Thresholds and bistability in HIV infection models with oxidative stress
preprint, January 2018


Life cycle synchronization is a viral drug resistance mechanism
text, January 2018

  • Neagu, Iulia A.; Olejarz, Jason; Freeman, Mark
  • Columbia University
  • DOI: 10.7916/d8vq4jks